|
|
|
-
Tuesday, July 29, 2025
2:51:19 PM HKT
|
|
|
|
|
Thursday, 22 March 2018, 10:16 HKT/SGT | |
| |
|
|
HONG KONG, Mar 22, 2018 - (ACN Newswire) - Differ Group Holding Company Limited ("DFH" or the "Company", together with its subsidiaries, the "Group", Stock code: 6878) a leading provider of short to medium-term financing and financing-related solutions in the PRC, is pleased to announce positive profit alert for 2017 annual results.
Based on the preliminary review and analysis of the unaudited management accounts of the Group, the net profit is expected to increase by 18% to 25% year-on-year for the year ended 31 December 2017 (For the year ended 31 December 2016, the net profit and earnings per share of the company were approximately RMB$142 million and RMB 3.20 cents respectively). The Group believes that the significant growth in net profit is mainly attributable to the increase in the revenue generated from the assets management business and finance lease services, as well as the impairment loss reduction on finance lease, loan and account receivables during the year.
The Group will announce its 2017 annual results on 28 March and further share views on its business development and future plan.
Topic: Press release summary
Sectors: Daily Finance, Daily News
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Tuesday, July 29, 2025 1:30:00 PM
|
|
|
GTJAI Achieved 'Carbon Neutrality' at Operational Level for the Third Consecutive Year
July 29, 2025 13:15 HKT/SGT
|
|
|
Unitree Races Toward IPO as Robot Applications Accelerate: Shoucheng Holdings Unlocks Dual-Engine Gains
July 29, 2025 11:30 HKT/SGT
|
|
|
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Tuesday, July 29, 2025 8:01:00 AM
|
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China
July 29, 2025 04:00 HKT/SGT
|
|
|
HKTDC boosts Hong Kong's competitive edge in high-value services
July 28, 2025 23:30 HKT/SGT
|
|
|
Intelligent Tech Unlocks the Future - Connecting the World, CITIC Telecom Unveils Future-ready Solutions at WAIC 2025
July 28, 2025 23:16 HKT/SGT
|
|
|
Phoenitron Grants Share Options and Sets HK$75 Million Profit Target for First Three Quarters
July 28, 2025 23:08 HKT/SGT
|
|
|
GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases
July 28, 2025 20:00 HKT/SGT
|
|
|
Doubleview Gold Corp Initiates Advanced Exploration Program at Red Spring, Bolstering Its Critical Minerals Portfolio
July 28, 2025 17:39 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
|
|
| |